Caduceus Mercurius
Holofractale de l'hypervérité
- Inscrit
- 14/7/07
- Messages
- 9 628
MAPS sent out the following news flash:
"The first subject was treated in Peter Gasser, MD's LSD/end-of-life anxiety study in Switzerland on May 13th. This marks the beginning of what will become the first LSD-assisted psychotherapy study in over 36 years. While we're sad that Albert Hofmann didn't live to actually see the first administration of LSD in this study, we're glad he knew the study was fully approved and that the initial subject was going to be enrolled in the study soon. This subject's second and final experimental session will take place on June 27. Dr. Gasser will be writing about the details of this initial research in his report for the upcoming Summer MAPS Bulletin."
Peter Gasser, MD
"The first subject was treated in Peter Gasser, MD's LSD/end-of-life anxiety study in Switzerland on May 13th. This marks the beginning of what will become the first LSD-assisted psychotherapy study in over 36 years. While we're sad that Albert Hofmann didn't live to actually see the first administration of LSD in this study, we're glad he knew the study was fully approved and that the initial subject was going to be enrolled in the study soon. This subject's second and final experimental session will take place on June 27. Dr. Gasser will be writing about the details of this initial research in his report for the upcoming Summer MAPS Bulletin."
Peter Gasser, MD